WHO publishes first guidelines for two Ebola treatments
Following a systematic review and meta-analysis of randomized clinical trials, the World Health Organization (WHO) has published its first guideline for Ebola virus disease therapeutics with new strong recommendations for the use of two monoclonal antibody treatments: mAb114 (Ansuvimab; Ebanga) and REGN-EB3 (Inmazeb). WHO calls on the global community to increase access to these lifesaving medicines. …